It turns out that US oil demand didn’t crater in July amid high prices


Back in July there was considerable hand-wringing about US oil demand cratering because of high prices. That went against decades of data showing the elasticity of oil demand.

In any case, the EIA is now out with revised estimates of demand and they show demand at 8.749 million barrels per day compared ot 8.460mbpd in 2020.

Moreover, because of spike in demand for flights and other products, total demand for US oil was way higher than 2020 and up compared to 2021 when crude prices were much lower.

The takeaway here is that gasoline demand is still highly inelastic and that a fresh spike in oil prices won’t cause a large degree of demand destruction.

WTI crude is trading down about 50-cents today as the market breathes a sigh of relief that Putin didn’t announce an escalation in Ukraine.

h/t @Giovanni Staunovo





Source link

Related articles

Tom Lee’s Bitmine Nears 5% of Ether Provide With $41M ETH Purchase – Bitcoin Information

Key TakeawaysBitmine Immersion Applied sciences added about $41 million value of ether final week.The corporate now holds over $16.2 billion in ETH, or greater than 4.9% of the present provide.Bitcoin treasury corporations Technique...

Baker Hughes indicators Venezuela offers focusing on oil, gasoline and LNG growth

(WO) — Baker Hughes has signed two agreements geared toward supporting oil and gasoline growth and increasing pure gasoline infrastructure in Venezuela, together with a strategic alliance with state-owned PDVSA targeted on gasoline...

OpenAI is sticking extra adverts in ChatGPT

OpenAI’s newest advert format will put photos of sponsored services and products in your display. The adverts, which OpenAI will start testing within the US later this month, will “initially” seem once you...

What One Liquidity Account Prices a Rising Dealer

Each liquidity account comes with one set of phrases protecting the value the dealer pays, the bounds it trades inside, and the classes the account covers. Regardless of the dealer routes via it...

Zenas BioPharma: Obexelimab Is Being Graded On The Mistaken Curve (NASDAQ:ZBIO)

This text was written byComply withI've a powerful inclination in direction of high-growth corporations, typically treading in sectors poised for exponential growth. My experience lies in understanding and investing in disruptive applied sciences...
spot_img

Latest articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

WP2Social Auto Publish Powered By : XYZScripts.com